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We report a case of acinar cell carcinoma of the pancreas with colon involvement that was difficult to distinguish from primary
coloncancer.A60-year-oldmanwasadmittedwitha1-monthhistoryofdiarrhea.Contrast-enhancedcomputedtomography(CT)
revealedalargetumor(10.6×11.6cm)atthesplenicflexureofthecolon.Colonoscopyshowedcompletelyroundulcerativelesions,
and biopsy revealed poorly differentiated adenocarcinoma. Left hemicolectomy, resection of the jejunum and pancreas body and
tail, and splenectomy were performed based on a diagnosis of descending colon cancer (cT4N0M0, stage IIB), and surgery was
consideredtobecurative.Diagnosiswassubsequentlyconfirmedasmoderatelydifferentiatedacinarcellcarcinomaofthepancreas
by immunohistochemical staining (pT3N0M0, stage IIA). Multiple liver metastases with portal thrombosis were found 8 weeks
postoperatively.DespitecombinationchemotherapywithoralS-1andgemcitabine,thepatientdiedofhepaticfailurewithnoeffect
of chemotherapy 14 weeks postoperatively. Correct diagnosis was difficult to determine preoperatively from the clinical, CT, and
colonoscopy findings. Moreover, the disease was extremely aggressive even after curative resection. Physicians should consider
pancreatic cancer in the differential diagnosis of similar cases.
1. Introduction
Acinar cell carcinoma of the pancreas (ACC) is a rare
malignant epithelial tumor representing 1-2% of all exocrine
pancreatic neoplasms [1]. Symptoms such as weight loss,
abdominalpain,nausea,andvomitingarenonspecificandare
relatedmostlytoeitherlocallyadvancedtumorsormetastasis
[1, 2]. We present in this report a case of ACC with colon
involvement that was difficult to distinguish from primary
colon cancer.
2. Case Presentation
A 60-year-old man with no remarkable past history was
admitted to our hospital in October 2011 with a 1-month
historyofdiarrheaandnonspecificlowerabdominalpain.He
alsocomplainedoflosing25kgwithintheprevious2months.
H ed i dn o tr e g u l a r l yd r i n ka l c o h o la n dh a dn oh i s t o r yo f
acute pancreatitis or trauma. On admission, a hard mass,
approximately15cminsize,withanirregularsurfacewaspal-
p a b l ei nt h el e fta b d o m e n .I n i t i a ll a b o r a t o r yt e s t sr e v e a l e da
white blood cell count of 23,960/𝜇L( n o r m a l :3 5 0 0 – 8 5 0 0 / 𝜇L;
91% neutrophils; normal: 46–61%), a hemoglobin level of
5.8 g/dL (normal: 13.5–17.0 g/dL), and a platelet count of
32.0×10
4/𝜇L (normal: 15–35×10
4/𝜇L). Serum carbohydrate
antigen 19.9 (CA19–9) was 48.9U/L (normal: 0–36.0U/L),
carcinoembryonic antigen (CEA) was 45.1ng/mL (normal:
0–4.9ng/mL), Span-1 was 36.0U/mL (normal: 0–30U/mL),
andsolubleinterleukin-2receptorwas(s-IL-2R)measuredas
high as 1137U/mL (normal: 188–570U/mL). Serum aspirate
aminotransferase, alanine aminotransferase, and amylase
were within the normal range.
Contrast-enhanced computed tomography (CT) showed
al a r g et u m o r( 1 0 . 6 ×11.6cm) at the splenic flexure of
the colon with an irregularly thickened wall (Figure 1).
Colonoscopy revealed completely round ulcerative lesions
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Figure 1: Preoperative abdominal computed tomography. (a) A
large tumor (10.6×11.6cm; enclosed by yellow circle) at the splenic
flexure with an irregularly thickened wall and involving the tail of
the pancreas; (b) tail of the pancreas (arrows).
Figure 2: Colonoscopic findings of widely dispersed, completely
round ulcerative lesions.
dispersed from the splenic flexure to the descending colon
(Figure 2). The pathological findings of the biopsy specimen
showed poorly differentiated adenocarcinoma. Except for
this area, colonoscopy showed normal mucosa throughout
the colon. Subsequent contrast-enhanced magnetic reso-
nance imaging and positron emission tomography revealed
no metastasis, including in the liver. Left hemicolectomy,
resection of the jejunum, resection of the pancreas body and
tail,andsplenectomywereperformedbasedonadiagnosisof
Figure 3: Macroscopic view of the resected tissue. In macroscopic
view, the transverse colon is visible on the upper surface of the
r e s e c t e dt i s s u e ,t h el a r g eu l c e ri sv i s i b l ea tt h ef r o n to ft h er e s e c t e d
tissue,andthedescendingcolonisvisibleonthelowersurfaceofthe
resected tissue. The pancreas stump is not visible.
descending colon cancer (cT4N0M0, stage IIB) in late Octo-
ber 2011. During surgery, the tumor was observed to invade
the jejunum and pancreas without involving the superior
mesenteric artery, superior mesenteric vein, or stomach. The
surgical specimen consisted of an irregular mass of tissue,
containing a portion of the left colon and the jejunum and
the pancreas and the spleen (14×9.5 ×7.0 cm) (Figure 3).
Curative resection was performed, but severe lymphatic and
venous invasion was found pathologically. Histopathology
revealed an acinar patternconsistingofcells growing in well-
formed acini, and a solid pattern characterized by sheets
and cords of cell separated by a thin fibrovascular stroma.
A positive periodic acid-Schiff reaction was noted following
diastase digestion in the cytoplasm and apical cytoplasmic
tips. Immunohistochemically, the tumor cells were diffusely
positive for pancytokeratin (AE1/AE3), focally positive for
lipase and trypsin, and negative for cytokeratin 7, cytokeratin
20, CDX2, and endocrine markers such as chromogranin,
synaptophysin, and CD56. From these morphological and
immunohistochemical findings, a final diagnosis was made
ofmoderatelydifferentiatedACCwithmultipleorgan(colon,
small bowel, and spleen) involvement (pT3N0M0, stage IIA;
Figure 4).Noincreasewasnotedinthelevelsofserumlipase,
amylase, or elastase-1 after the operation. Despite an appar-
ently curative resection, multiple liver metastases and portal
thrombosis were found 8 weeks after surgery (Figure 5).
SerumDUPAN-2was191U/L(normal:0–150U/L).However,
Serum CA19-9, CEA, Span-1, and alpha-fetoprotein (AFP)
were within the normal range. Combination chemotherapy
with oral S-1 (tegafur, 5-chloro-2,4-dihydroxypyridine, and
oteracilpotassiumina1:0.4:1molarratio;80mg/body ,days
1–14/q3w [3]) and gemcitabine (30min intravenous injection
of 1000mg/m
2 o nd a y s1a n d8o fe a c h2 1 - d a yc y c l e )w a s
administered. However, the patient died of hepatic failure 14
weeksaftersurgery,withnoeffectofchemotherapyobserved.
3. Discussion
Commonly referred clinical symptoms of ACC are upper
abdominal pain, weight loss, nausea, and vomiting [1, 2]. In
our case, it was diarrhea that led us to discover ACC as theCase Reports in Medicine 3
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Figure 4: Microscopic findings of the resected tumor. (a) Acinar pattern consisting of well-formed acinar structures (hematoxylin and eosin
staining, ×200); (b) a positive periodic acid-Schiff reaction followed diastase digestion within the cytoplasm and apical cytoplasmic tips
(×200); tumor cells were focally positive for (c) lipase and (d) trypsin (×200).
Figure 5: Abdominal computed tomography at the time of recur-
rence. Multiple liver metastases with portal thrombosis were found
8 weeks after surgery.
neoplasm in the tail part of the pancreas, where it involved
the colon expansively and formed a stricture. ACC often
produces digestive enzymes such as trypsin, chymotrypsin,
lipase, and amylase [1]. However, there were no increases in
thelevelsofserumlipase,amylase,orelastase-1inthepresent
case, and we did not measure serum trypsin.
According to the initial symptoms of diarrhea, lower
abdominal pain, and body weight loss, as well as the finding
of the palpable mass in the left abdomen, colorectal cancer
was considered the most probable diagnosis. In addition, CT
showed a large, well-defined tumor mainly at the splenic
flexure of the colon in contact with a part of the pancreas
tail. Round ulcerative lesions of about 20cm, detected by
colonoscopy inside the colon, were an atypical finding of
colon cancer. s-IL-2 R levels were as high as 1137U/mL.
We therefore suspected malignant lymphoma in addition to
coloncancer,despitethefactthatprimarycoloniclymphoma
is rare [4], and we did not consider differential diagnosis
of pancreatic tumor, including pancreatic cancer and solid
pseudopapillary tumor. Based on the CT findings alone,
solid pseudopapillary tumor of the pancreas would also
have been a differential diagnosis because CT showed the
patient’s tumor as a large solid pseudopapillary tumor [5].
H o w e v e r ,t h ep a t i e n tw a se l d e r l ya n dt h et u m o rd i dn o ti n
fact have characteristic findings of a solid pseudopapillary
tumor, such as calcification or a combination of solid and
cystic components. We also considered that severe stenosis
in the descending colon was the cause of diarrhea and that
an operation was needed to avoid complete obstruction of
the bowel. Surgery was subsequently performed based on a
working diagnosis of descending colon cancer.
Grossexaminationrevealedanannularconstrictingmass
that appeared to be growing into the wall of the colon from
t h eo u t s i d ea n dp u s h i n go n t ot h em u c o s a ,r e s u l t i n gi nf o c a l
areas of ulceration. No heterotopic pancreatic tissue was
seen in the colon. Tumor cells were negative for both CK20
and CDX2, specific markers of adenocarcinoma of intestinal
origin. Taken together, moderately differentiated ACC with
multiple organ involvement was diagnosed.
It is rare to find colon involvement in pancreatic cancer
[6]. The most common sites of metastasis in ductal cell4 Case Reports in Medicine
carcinoma are the liver (21–80%), lung (7–28%), abdomen
(25%), regional lymph nodes (18–25%), and peritoneum (11–
23%) [7]. Cases of ACC with colon involvement are also
q u i t er a r e[ 8]. The metastatic rate of ACC at presentation
is reported to be 30–50%, with the liver being the most
common site [1, 2, 9] .I no u rp a t i e n t ,i tw a sd i ffi c u l tt o
determine the correct diagnosis preoperatively on the basis
of clinical symptoms and physical, CT, and colonoscopy
findings. However, such findings may be indicative of ACC
since this type of cancer is reported to develop from the
parenchymaofthepancreas,showinvasiveexophyticgrowth
with only mild changes in pancreatic tissue, and be large (on
average, 10cm in diameter) and circumscribed [1].
R e p o r t sf r o maf e ws m a l lc a s es e r i e sh a v ei n d i c a t e dt h a t ,
compared with ductal cell carcinoma, ACC is considered
to have good prognosis if completely resected [2, 10, 11]. A
better prognosis can also be anticipated in patients younger
than 60 years with a non-lipase-secreting tumor of <10cm
[1]. In another study, multivariable analysis revealed that age
<65, well-differentiated tumor tissue, and negative resection
margins were independent prognostic factors for acinar cell
carcinoma [12]. We consider that our patient had extremely
aggressive disease, even after what was deemed a curative
resection, because he had worsened prognostic factors such
as advanced age, large tumor size, and severe lymphatic and
venous invasion histologically in the resected specimen.
ProductionofAFPhasbeenreportedasapossiblemarker
of ACC [2]. In the present case, serum levels of CEA,
CA19-9, Span-1, and AFP were all within the normal range
when multiple liver metastases were found. Therefore, these
markers, which are conventionally used as initial indicators
of tumor, were ineffective in our patient.
No optimal strategy has yet been determined for patients
with synchronous or recurrent liver metastasis from ACC. It
has been reported that gemcitabine is not sufficiently effica-
cious against this cancer, despite its wide use as a standard
agent for the treatment of pancreatic adenocarcinoma [13].
Some case studies have reported tumor shrinkage through
the use of fluoropyrimidine-based treatment [2]. In our
patient, however, combination chemotherapy with oral S-
1 and gemcitabine had no therapeutic effect. This relatively
rare case of ACC with colon involvement was difficult to
distinguish from colon cancer preoperatively. Moreover, the
diseasewasextremelyaggressiveevenaftercurativeresection
and chemotherapy. Physicians should consider pancreatic
cancer as a differential diagnosis in similar cases.
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